Arancha Cebrian

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Metabolic regulation of histone acetylation by ACLY supports MDR1 expression in colorectal cancer and highlights a targetable vulnerability.

Metabolic regulation of histone acetylation by ACLY supports MDR1 expression in colorectal cancer and highlights a targetable vulnerability.

Journal: Neoplasia (New York, N.Y.)

Published: April 01, 2026

Aurora kinase A drives non-canonical YAP1/TAZ crosstalk to sustain primary resistance to anti-EGFR therapies in colorectal cancer.

Aurora kinase A drives non-canonical YAP1/TAZ crosstalk to sustain primary resistance to anti-EGFR therapies in colorectal cancer.

Journal: Molecular therapy. Oncology

Published: February 15, 2025

Reply to Dr. Rafael Rosell: Shedding some light on the unresolved issue of YAP1 Ser397 phosphorylation in cancer.

Reply to Dr. Rafael Rosell: Shedding some light on the unresolved issue of YAP1 Ser397 phosphorylation in cancer.

Journal: British journal of cancer

Published: May 27, 2024

POLQ immunostaining behaves as a prognostic factor for pancreatic carcinoma.

POLQ immunostaining behaves as a prognostic factor for pancreatic carcinoma.

Journal: Frontiers in oncology

Published: May 15, 2024

Correction: Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells.

Correction: Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells.

Journal: British journal of cancer

Published: April 04, 2024

Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells.

Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells.

Journal: British journal of cancer

Published: October 16, 2023

Vitamin-C-dependent downregulation of the citrate metabolism pathway potentiates pancreatic ductal adenocarcinoma growth arrest.

Vitamin-C-dependent downregulation of the citrate metabolism pathway potentiates pancreatic ductal adenocarcinoma growth arrest.

Journal: Molecular oncology

Published: July 31, 2023

Galectin-1, a novel promising target for outcome prediction and treatment in SCLC.

Galectin-1, a novel promising target for outcome prediction and treatment in SCLC.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: August 02, 2022

Choline Kinase α Inhibitors MN58b and RSM932A Enhances the Antitumor Response to Cisplatin in Lung Tumor Cells.

Choline Kinase α Inhibitors MN58b and RSM932A Enhances the Antitumor Response to Cisplatin in Lung Tumor Cells.

Journal: Pharmaceutics

Published: April 07, 2022

Ras Family of Small GTPases in CRC: New Perspectives for Overcoming Drug Resistance.

Ras Family of Small GTPases in CRC: New Perspectives for Overcoming Drug Resistance.

Journal: Cancers

Published: June 25, 2021

TRIM72 Immunohistochemical Expression Can Predict Relapse in Colorectal Carcinoma.

TRIM72 Immunohistochemical Expression Can Predict Relapse in Colorectal Carcinoma.

Journal: Pathology oncology research : POR

Published: October 08, 2018

Prognostic significance of neutrophil-to lymphocyte ratio and platelet-to lymphocyte ratio in older patients with metastatic colorectal cancer.

Prognostic significance of neutrophil-to lymphocyte ratio and platelet-to lymphocyte ratio in older patients with metastatic colorectal cancer.

Journal: Journal of geriatric oncology

Published: June 13, 2018

Showing 1-12 of 25

Last Updated: 09/26/2026